News
Lloyds and Day Lewis Pharmacy listings
Vamousse® Advertising and Marketing Award
25 February 2015
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is delighted to announce new listings for its Vamousse® Head Lice Treatment and Protective products with Lloyds Pharmacy and its Treatment product with Day Lewis Pharmacy in the UK.
Day Lewis, which began stocking the Vamousse range in January 2015, is the largest independent pharmacy chain in the UK with more than 200 outlets. Lloyds, a well respected household name at the forefront of community pharmacy, has a distribution network of more than 1600 outlets in the UK and is expected to commence stocking Vamousse products from March 2015.
Vamousse - broadening the distribution network
With distribution already established in Boots, Superdrug, Sainsbury's, Tesco and Rowlands, the addition of Lloyds and Day Lewis gives Vamousse a comprehensive UK distribution platform for 2015. Increasing the physical distribution points is particularly important for head lice products that tend to be emergency purchases. Customers need to be able to find the products close to home in order to solve their head lice problems as fast as possible.
Vamousse - advertising and marketing campaign award
TyraTech is particularly pleased that the Vamousse brand has won the Independent Community Pharmacy (ICP) magazine 'Pharmacy Product Of The Year - Best Advertising Campaign' award. This prestigious award is voted for by practicing pharmacists. The award recognises and reflects the strong awareness and engagement generated by the Vamousse marketing campaign amongst pharmacists and pharmacy staff. Their awareness and recommendation of the Vamousse Treatment and Protective range are key ingredients in the commercial success of these products.
Bruno Jactel CEO of TyraTech commented:
"We are delighted to announce these new listings for our Vamousse treatment and preventative products, taking us initially into more than 1300 new distribution points in the UK from March 2015.
"I am very pleased with our achievements in the UK marketplace in the eight months since the launch of the Vamousse product range. We are confident of continued positive developments as our comprehensive UK distribution platform reaps the benefits of our highly engaging and effective marketing campaign."
For further information please contact:
| TyraTech Inc. Bruno Jactel, Chief Executive Officer Vincent Morgus, Chief Financial Officer and Treasurer |
Tel: +1 919 415 4340 Tel: +1-919-415-4287 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44 203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: 44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins |
Tel: 44 20 7087 4550 |
| Walbrook, Financial PR and IR Nick Rome/ Guy McDougall |
Tel: +44 20 7933 8792 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.